Bromothalonil, also known as Methyldibromo glutaronitrile (MDBGN), is a widely used preservative that can be found in many personal hygiene and industrial products. It is also a known allergen and... It is also a known allergen and dermatological irritant that has been banned in many EU countries due to increasing rates of contact allergy.
- Primary indication
- Bromothalonil is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.Curator reviewed
- Formula / weight
- C6H6Br2N2 · 265.936 g/mol (avg)
- First approval
- United States, 2012
- Also known as
- BBMG · MDBGN · Methyldibromo Glutaronitrile · Methyldibromoglutaronitrile
Resolves to
Clinical / RWD
Structure
InChIKey
DHVLDKHFGIVEIP-UHFFFAOYSA-NSMILESBrCC(Br)(CCC#N)C#NWhat you can answer from here — as of April 02, 2025
Which companies are running trials of Bromothalonil, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account